JNBA Financial Advisors’s Oncolytics Biotech ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$200 Buy
+210
New +$195 ﹤0.01% 815
2026
Q1
Sell
-210
Closed -$184 865
2025
Q4
$184 Hold
210
﹤0.01% 787
2025
Q3
$294 Hold
210
﹤0.01% 644
2025
Q2
$163 Hold
210
﹤0.01% 645
2025
Q1
$116 Hold
210
﹤0.01% 643
2024
Q4
$192 Hold
210
﹤0.01% 640
2024
Q3
$183 Hold
210
﹤0.01% 644
2024
Q2
$208 Hold
210
﹤0.01% 630
2024
Q1
$223 Hold
210
﹤0.01% 658
2023
Q4
$284 Hold
210
﹤0.01% 689
2023
Q3
$458 Hold
210
﹤0.01% 708
2023
Q2
$546 Hold
210
﹤0.01% 684
2023
Q1
$252 Hold
210
﹤0.01% 707
2022
Q4
$342 Hold
210
﹤0.01% 640
2022
Q3
$0 Hold
210
﹤0.01% 735
2022
Q2
$0 Hold
210
﹤0.01% 742
2022
Q1
$0 Hold
210
﹤0.01% 796
2021
Q4
$0 Hold
210
﹤0.01% 859
2021
Q3
$0 Hold
210
﹤0.01% 747
2021
Q2
$1K Hold
210
﹤0.01% 660
2021
Q1
$1K Hold
210
﹤0.01% 629
2020
Q4
$0 Hold
210
﹤0.01% 629
2020
Q3
$0 Hold
210
﹤0.01% 584
2020
Q2
$0 Hold
210
﹤0.01% 579
2020
Q1
$0 Hold
210
﹤0.01% 601
2019
Q4
$1K Hold
210
﹤0.01% 587
2019
Q3
$0 Hold
210
﹤0.01% 669
2019
Q2
$0 Hold
210
﹤0.01% 691
2019
Q1
$0 Hold
210
﹤0.01% 559
2018
Q4
$0 Buy
+210
New +$569 ﹤0.01% 673
2018
Q3
Sell
-210
Closed -$1K 638
2018
Q2
$1K Buy
+210
New +$1.29K ﹤0.01% 517

Other funds holding ONCY

JNBA Financial Advisors's ONCY Position: Q2 2026 in Review

JNBA Financial Advisors opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 210 shares worth $200. The stake represents ﹤0.01% of the portfolio and ranks #815 among its holdings. This is a return to the name: JNBA Financial Advisors previously reported a position in ONCY as recently as Q4 2025.

JNBA Financial Advisors first reported a position in ONCY in Q2 2018 and has held it in 31 quarters since. The position peaked at $1K in Q2 2021. 24 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • JNBA Financial Advisors held 210 shares of Oncolytics Biotech worth $200 as of Q2 2026.
  • Oncolytics Biotech was a new JNBA Financial Advisors position in Q2 2026.
  • Oncolytics Biotech made up ﹤0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #815 holding.
  • JNBA Financial Advisors first reported a position in Oncolytics Biotech in Q2 2018 and has held it in 31 quarters since.
  • JNBA Financial Advisors's Oncolytics Biotech position peaked at $1K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.